By Abhisam Training Software
Abstract:
The US FDA has decided to implement the "Pedigree provisions" of the Prescription Drugs Marketing Act after December 2006, when the current stay on it expires. There is a lot of concern that many pharmaceutical supply chain participants, may not be able to meet this deadline and hence risk non compliance with the provisions of the act. This pharmaceutical article is excerpts from the pharmaceutical article (white paper) written by Sangeeta of Abhisam Software. The pharmaceutical white paper attempts to present a solution to ensure timely compliance and get added side benefits in the process.
Tidak ada komentar:
Posting Komentar